2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1003123415 M.D. PH.D.
Verify on CMS →

GIANLUCA IACOBELLIS, M.D. PH.D.

Endocrinology, Diabetes & Metabolism Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 501 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
36%
generic claims · 64% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3101/100
▼ 2 pts below national avg 83.1 · [object Object]

What the federal data shows

GIANLUCA IACOBELLIS, M.D. PH.D. reported a CMS MIPS final score of 81.3101/100 — below the 83.1 national average — and filed 4,260 Medicare Part D claims in 2023.

81.3101/100
MIPS score · -2 vs avg
4K
Part D claims, 2023
36%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GIANLUCA IACOBELLIS, M.D. PH.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GIANLUCA IACOBELLIS, M.D. PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GIANLUCA IACOBELLIS, M.D. PH.D.?

Near national average

NPI registry status

Active

Issued 09/07/2010

NPI 1003123415

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

4,260 61% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

81.3101/100 1.7898999999999887% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

GIANLUCA IACOBELLIS, M.D. PH.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
81.3101/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 81.3101/100 vs national avg 83.1

0%100%National avg83%81.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 81.3101/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GIANLUCA IACOBELLIS, M.D. PH.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. PH.D. credentials at 1450 NW 10TH AVE, MIAMI, FL, 33136, with a listed phone of (305) 243-3636. NPI 1003123415 was issued on 09/07/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what IACOBELLIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,260 prescription claims written by this provider, covering 501 Medicare beneficiaries and totaling roughly $3.3 million in drug spend, split 64% brand-name and 36% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3101/100 for the 2023 performance year (Quality 78.455, Cost 50.5984), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1450 NW 10TH AVE
MIAMI, FL 33136

Provider Details

NPI 1003123415
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D. PH.D.
Gender Male
NPI Issued 09/07/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.3101
Final Score
Avg: 83.1
78.455
Quality
50.5984
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where GIANLUCA IACOBELLIS, M.D. PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF MIAMI
MIAMI, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to GIANLUCA IACOBELLIS, M.D. PH.D.. To verify GIANLUCA IACOBELLIS, M.D. PH.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

GIANLUCA IACOBELLIS, M.D. PH.D. — brand share 64.0%
Specialty average (est.)

64% brand-name claims vs 36% generic, on 4,260 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,260
Total Claims
$3.3M
Total Drug Cost
501
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,682
Total Day Supply
257,315
Brand vs Generic
64% brand / 36% generic
Brand Drug Cost
$3.2M
Generic Drug Cost
$24K

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
2.06
Gender Split
49% female / 51% male
Age Distribution
<65: 89, 65-74: 266, 75-84: 125, 85+: 21

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GIANLUCA IACOBELLIS, M.D. PH.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
374
Jardiance
Empagliflozin
334
Metformin Hcl
286
Ozempic
Semaglutide
263
Novolog Flexpen
Insulin Aspart
208
Tresiba Flextouch U-100
Insulin Degludec
159
Levothyroxine Sodium
134
Farxiga
Dapagliflozin Propanediol
98
Metformin Hcl Er
Metformin Hcl
86
Mounjaro
Tirzepatide
84

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How GIANLUCA IACOBELLIS, M.D. PH.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

GIANLUCA IACOBELLIS, M.D. PH.D.'s 4,260 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as IACOBELLIS.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GIANLUCA IACOBELLIS, M.D. PH.D.'s specialty?
GIANLUCA IACOBELLIS, M.D. PH.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MIAMI, Florida. Credentials: M.D. PH.D..
How much does GIANLUCA IACOBELLIS, M.D. PH.D. prescribe under Medicare Part D?
In 2023, GIANLUCA IACOBELLIS, M.D. PH.D. wrote 4,260 Medicare Part D claims totaling $3.3M in drug costs for 501 beneficiaries.
What is GIANLUCA IACOBELLIS, M.D. PH.D.'s Medicare quality score?
GIANLUCA IACOBELLIS, M.D. PH.D. has a CMS MIPS Final Score of 81.3101/100 (Quality: 78.455, Cost: 50.5984). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GIANLUCA IACOBELLIS, M.D. PH.D. located?
GIANLUCA IACOBELLIS, M.D. PH.D. is located at 1450 NW 10TH AVE, MIAMI, FL, 33136. Phone: (305) 243-3636.
What is GIANLUCA IACOBELLIS, M.D. PH.D.'s NPI number?
GIANLUCA IACOBELLIS, M.D. PH.D.'s National Provider Identifier (NPI) is 1003123415, issued on 09/07/2010.
Does GIANLUCA IACOBELLIS, M.D. PH.D. prescribe more brand-name or generic drugs?
GIANLUCA IACOBELLIS, M.D. PH.D.'s prescribing is 64% brand-name and 36% generic drugs by claim count, with $3.2M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does GIANLUCA IACOBELLIS, M.D. PH.D. prescribe most often?
Based on 2023 Medicare Part D data, GIANLUCA IACOBELLIS, M.D. PH.D.'s most frequently prescribed drugs include Trulicity, Jardiance, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GIANLUCA IACOBELLIS, M.D. PH.D. accept Medicare?
GIANLUCA IACOBELLIS, M.D. PH.D. appears in CMS Medicare data with 4,260 Part D claims and 501 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GIANLUCA IACOBELLIS, M.D. PH.D.'s credentials?
GIANLUCA IACOBELLIS, M.D. PH.D.'s NPI is 1003123415 with credentials M.D. PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology